1,211 results on '"Desai, Nihar R."'
Search Results
52. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy
53. Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association
54. Relation of Cardiovascular Risk Factors to Mortality and Cardiovascular Events in Hospitalized Patients With Coronavirus Disease 2019 (from the Yale COVID-19 Cardiovascular Registry)
55. Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
56. Socio-Economic Burden of Myocardial Infarction Among Cancer Patients
57. Physician variation in the de-adoption of ineffective statin and fibrate therapy
58. Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation
59. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation
60. Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart Failure
61. Lipoprotein(a) levels and association with myocardial infarction and stroke in a nationally representative cross-sectional US cohort
62. Psychiatric Comorbidity and Outcomes After Left Ventricular Assist Device Implantation for End-Stage Heart Failure
63. Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States
64. Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction
65. Impact of Digital Health Technology on Quality of Life in Patients With Heart Failure
66. Rationale, Design, and Patient Characteristics of a Cluster-Randomized Pragmatic Trial to Improve Mineralocorticoid Antagonist Use
67. Clinical Phenotyping with an Outcomes-driven Mixture of Experts for Patient Matching and Risk Estimation
68. Managing the economic challenges in the treatment of heart failure
69. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis
70. National Trends in Incidence and Outcomes of Patients With Heart Failure Requiring Respiratory Support
71. Digoxin Use and Associated Adverse Events Among Older Adults
72. National Trends in Healthcare-Associated Infections for Five Common Cardiovascular Conditions
73. Comfort Measures Only in Myocardial Infarction: Prevalence of This Status, Change Over Time, and Predictors From a Nationwide Study
74. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)
75. Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications
76. Serum Potassium and Mortality in High-Risk Patients: SPRINT
77. Physician Network Connections Associated With Faster De-Adoption of Dronedarone for Permanent Atrial Fibrillation
78. Trends in 30-Day Readmission Rates for Medicare and Non-Medicare Patients in the Era of the Affordable Care Act
79. ACC/AHA Hypertension Guidelines and CHA2DS2-VASc Up-Scoring in Patients With Atrial Fibrillation
80. Electronic health record alerts for management of heart failure with reduced ejection fraction in hospitalized patients: the PROMPT-AHF trial
81. Healthcare Market-Level and Hospital-Level Disparities in Access to and Utilization of High-Quality Hip and Knee Replacement Hospitals Among Medicare Beneficiaries
82. Practical solutions for implementation of blood cholesterol guidelines in clinical practice
83. Hospital Characteristics Associated With Postdischarge Hospital Readmission, Observation, and Emergency Department Utilization
84. Value in Healthcare Initiative: Summary and Key Recommendations
85. Moving toward combination lipid-lowering therapy for all patients with atherosclerotic cardiovascular disease
86. Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States
87. Patterns of Care and Outcomes of Ambulatory Endovascular Interventions in Lower Extremity Peripheral Arterial Disease
88. Trends in Spending and Claims for P2Y12 Inhibitors by Medicare and Medicaid From 2015 to 2020
89. Prevalence And Excess Risk Of Hospitalization In Heart Failure With Reduced Ejection Fraction
90. Abstract 16705: Prevalence and Outcomes Among Hospitalized Patients With Covid-19 and Atrial Fibrillation or Flutter
91. Abstract 16397: Presence of Myocardial Injury on Admission is Associated With an Increase in All-cause Mortality in Patients With COVID-19
92. Abstract 15072: Thirty Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries With Heart Failure
93. Abstract 14603: Arterial Vascular Events in Men With Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS)
94. Abstract 14563: Improved Outcomes in Patients With Anthracycline-Induced Cardiomyopathy Undergoing Left Ventricular Assist Devices: 10-Year Longitudinal INTERMACS Study
95. Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial Fibrillation
96. The Impact of the Transition From Volume to Value on Heart Failure Care: Implications of Novel Payment Models and Quality Improvement Initiatives
97. Relative Costs of Surgical and Transcatheter Aortic Valve Replacement and Medical Therapy
98. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure
99. Relationship Between Patient-Reported Hospital Experience and 30-Day Mortality and Readmission Rates for Acute Myocardial Infarction, Heart Failure, and Pneumonia
100. Essential Elements of Early Post Discharge Care of Patients with Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.